- Home
- CTOR vs RFM Comparison
CTOR vs RFM Comparison
Compare CTOR & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOR
- RFM
- Stock Information
- Founded
- CTOR 2021
- RFM 2020
- Country
- CTOR United States
- RFM United States
- Employees
- CTOR N/A
- RFM N/A
- Industry
- CTOR
- RFM Finance/Investors Services
- Sector
- CTOR
- RFM Finance
- Exchange
- CTOR NYSE
- RFM Nasdaq
- Market Cap
- CTOR 63.7M
- RFM 86.0M
- IPO Year
- CTOR N/A
- RFM N/A
- Fundamental
- Price
- CTOR $5.30
- RFM $14.14
- Analyst Decision
- CTOR Buy
- RFM
- Analyst Count
- CTOR 2
- RFM 0
- Target Price
- CTOR $6.00
- RFM N/A
- AVG Volume (30 Days)
- CTOR 3.3M
- RFM 20.7K
- Earning Date
- CTOR 08-11-2025
- RFM 01-01-0001
- Dividend Yield
- CTOR N/A
- RFM 9.74%
- EPS Growth
- CTOR N/A
- RFM N/A
- EPS
- CTOR N/A
- RFM N/A
- Revenue
- CTOR N/A
- RFM N/A
- Revenue This Year
- CTOR N/A
- RFM N/A
- Revenue Next Year
- CTOR N/A
- RFM N/A
- P/E Ratio
- CTOR N/A
- RFM N/A
- Revenue Growth
- CTOR N/A
- RFM N/A
- 52 Week Low
- CTOR $0.55
- RFM $12.89
- 52 Week High
- CTOR $49.00
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- CTOR N/A
- RFM 58.02
- Support Level
- CTOR N/A
- RFM $13.99
- Resistance Level
- CTOR N/A
- RFM $14.12
- Average True Range (ATR)
- CTOR 0.00
- RFM 0.09
- MACD
- CTOR 0.00
- RFM 0.03
- Stochastic Oscillator
- CTOR 0.00
- RFM 95.38
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.